Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 14, 2020; 26(30): 4489-4500
Published online Aug 14, 2020. doi: 10.3748/wjg.v26.i30.4489
Table 2 Outcomes after portal vein embolization with or without transarterial chemoembolization and before hepatectomy
VariablesiTP group (n = 13)seTP group (n = 17)PVE-only group (n = 21)P value
FLR (%) (before hepatectomy)45.9 ± 4.243.3 ± 6.643.0 ± 4.70.262
Interval from TACE/PVE to hepatectomy16.2 ± 2.737.9 ± 6.535.4 ± 10.6< 0.001
KGR (%)21.1 ± 5.97.6 ± 2.96.8 ± 3.6< 0.001
Tumor size reduction, n (%)13 (100)13 (76)2 (10)< 0.001
Complications, n (%)0.875
Abdominal pain6 (46)9 (53)3 (14)
Fever7 (54)8 (47)3 (14)
Nausea2 (15)4 (24)2 (10)
Acute pulmonary infarction01 (6)0